Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

A novel EGFR isoform confers increased invasiveness to cancer cells.

Zhou M, Wang H, Zhou K, Luo X, Pan X, Shi B, Jiang H, Zhang J, Li K, Wang HM, Gao H, Lu S, Yao M, Mao Y, Wang HY, Yang S, Gu J, Li C, Li Z.

Cancer Res. 2013 Dec 1;73(23):7056-67. doi: 10.1158/0008-5472.CAN-13-0194.

2.
3.

Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.

Luwor RB, Baradaran B, Taylor LE, Iaria J, Nheu TV, Amiry N, Hovens CM, Wang B, Kaye AH, Zhu HJ.

Oncogene. 2013 May 9;32(19):2433-41. doi: 10.1038/onc.2012.260.

4.

The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.

Zhang Z, Liu ZB, Ren WM, Ye XG, Zhang YY.

Int J Mol Med. 2012 Oct;30(4):856-62. doi: 10.3892/ijmm.2012.1059.

PMID:
22797360
5.
6.

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.

Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.

Oncogene. 2008 May 15;27(22):3201-10. doi: 10.1038/sj.onc.1210983.

PMID:
18193092
7.

MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.

Chen CH, Wang SW, Chen CW, Huang MR, Hung JS, Huang HC, Lin HH, Chen RJ, Shyu MK, Huang MC.

Gynecol Oncol. 2013 Mar;128(3):560-7. doi: 10.1016/j.ygyno.2012.12.012.

PMID:
23262208
8.

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G.

Clin Cancer Res. 2005 Dec 1;11(23):8288-94.

9.

MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.

Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, Qian W, O'Malley YQ, Askeland RW, Sugg SL, Qian J, Lin J, Jiang Z, Yee AJ, Sefton M, Deng Z, Shan SW, Wang CH, Yang BB.

J Cell Sci. 2013 Mar 15;126(Pt 6):1440-53. doi: 10.1242/jcs.118299.

10.
11.

DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.

Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.

Exp Cell Res. 2004 Sep 10;299(1):91-100.

PMID:
15302576
12.

Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.

Madarame J, Higashiyama S, Kiyota H, Madachi A, Toki F, Shimomura T, Tani N, Oishi Y, Matsuura N.

Prostate. 2003 Nov 1;57(3):187-95.

PMID:
14518027
13.

Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.

Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.

Cancer Res. 2006 Jan 15;66(2):867-74.

14.

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Turner T, Chen P, Goodly LJ, Wells A.

Clin Exp Metastasis. 1996 Sep;14(4):409-18.

PMID:
8878415
15.

Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.

Akca H, Tani M, Hishida T, Matsumoto S, Yokota J.

Lung Cancer. 2006 Oct;54(1):25-33.

PMID:
16872715
16.

Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.

Tysnes BB, Haugland HK, Bjerkvig R.

Invasion Metastasis. 1997;17(5):270-80.

PMID:
9876221
17.

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.

Alper O, Bergmann-Leitner ES, Bennett TA, Hacker NF, Stromberg K, Stetler-Stevenson WG.

J Natl Cancer Inst. 2001 Sep 19;93(18):1375-84.

PMID:
11562388
18.

Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation.

Luwor RB, Chin X, McGeachie AB, Robinson PJ, Zhu HJ.

Growth Factors. 2012 Aug;30(4):220-9. doi: 10.3109/08977194.2012.683189.

PMID:
22574813
19.
20.

Heparin binding EGF is necessary for vasospastic response to endothelin.

Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, Tharaux PL.

FASEB J. 2006 Sep;20(11):1936-8.

PMID:
16877529

Supplemental Content

Support Center